Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial.
By Jeffrey L. Saver, R. Jahan, E. Levy, T. Jovin, B. Baxter, R. Nogueira, W. Clark, R. Budzik, O. Zaidat. The Lancet, 2012
1,328 citations recorded by the source corpus.
Subfields: Epidemiology, Neurology
View Paper: https://www.semanticscholar.org/paper/c8dfa00140f4ca5f877fa308c5103c2fd8911dd2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Neurology
Citations in the corpus
- Endovascular therapy for ischemic stroke with perfusion-imaging selection. (2015, neutral): “Symptomatic intracerebral hemorrhage‖ 2 (6) 0 NA NA −6 (−13 to 2)** 0.”
- Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke: A Consensus Statement (2013, methodology): “1% difference in the Solitaire FR and Merci arms, respectively).(1) Nevertheless, TIMI has been predictive of”
- Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. (2015, neutral): “Diabetes mellitus 15/97 (15) 12/98 (12)”
- Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke (2018, neutral): “This was assessed with the use of core laboratory adjudication in most studies, and it has been shown that local sites tend to overestimate the degree of reperfusion compared with a core laboratory (99).”